Association between liver enzymes and metabolic syndrome in Canadian adults: results from the Canadian health measures survey - cycles 3 &4
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Background The relationship between liver enzymes and Metabolic Syndrome (MetS) in different populations, including Canadians, is not consistent and well understood. We used the Canadian Health Measures Survey data (Cycles 3 and 4) to examine the cross-sectional relationships between select liver biomarkers and MetS in the adult Canadian population. The biomarkers selected were gamma-glutamyl transferase (GGT), aspartate aminotransferase (AST), and alkaline phosphatase (ALKP).Methods Fasting blood samples (FBS) were collected from adults above the age of 20 years for Cycle 3 and Cycle 4 (n = 3003). MetS was diagnosed if the subjects had three or more risk determinants according to the Joint Interim Statement criteria. Primary risk factors included quartile cut-offs for each of the biomarkers ALKP, AST, GGT for males and females separately. A multivariable logistic regression technique based on a maximum likelihood approach was used to evaluate the association between quartiles of ALKP, AST, and GGT, other individual and contextual factors, and the prevalence of MetS.Results MetS was prevalent in 32.3% of subjects. BMI was an effect modifier in the relationship between GGT and MetS prevalence, while sex was an effect modifier in the relationship between ALKP and MetS prevalence; and age was an effect modifier in the relationship between AST and MetS prevalence.Conclusions Since the mechanisms to underpin the associations between the liver enzymes activity and MetS are unknown, further epidemiologic investigations using longitudinal designs are necessary to understand these associations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
The Global Epidemic of the Metabolic Syndrome
Saklayen, M. G. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0812-z · Cited by 3,990 · cited 1×
“Metabolic syndrome (MetS) has become an important global public health issue [1, 2].”
BackgroundThe Metabolic Syndrome and Cardiovascular Risk
Mottillo, S., Filion, K. B., Genest, J., Joseph, L., Pilote, L., Poirier, P., Rinfret, S., Schiffrin, E. L., & Eisenberg, M. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.034 · Cited by 3,009
Park, Y.-W., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, M. R., & Heymsfield, S. B. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.4.427 · Cited by 2,074
Evaluation of Abnormal Liver-Enzyme Results in Asymptomatic Patients
Pratt, D. S., & Kaplan, M. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004273421707 · Cited by 1,203 · cited 1×
“AST is a less specific marker of liver injury because it also exists in other organs and cells, such as the heart, kidneys, and lungs [25, 39].”
BackgroundGender differences in insulin resistance, body composition, and energy balance
Geer, E. B., & Shen, W. (2009) · Gender Medicine · doi:10.1016/j.genm.2009.02.002 · Cited by 913 · cited 1×
“[41] are not known, it has been suggested that sex differences in the distribution of total body adipose tissue and sex hormones may play a role [43].”
BackgroundSchindhelm, R. K., Dekker, J. M., Nijpels, G., Bouter, L. M., Stehouwer, C. D. A., Heine, R. J., & Diamant, M. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.04.006 · Cited by 420
Liver Markers and Development of the Metabolic Syndrome
Hanley, A. J. G., Williams, K., Festa, A., Wagenknecht, L. E., D’Agostino, R. B., & Haffner, S. M. (2005) · Diabetes · doi:10.2337/diabetes.54.11.3140 · Cited by 419
Elevations in Markers of Liver Injury and Risk of Type 2 Diabetes
Hanley, A. J. G., Williams, K., Festa, A., Wagenknecht, L. E., D’Agostino, R. B., Kempf, J., Zinman, B., & Haffner, S. M. (2004) · Diabetes · doi:10.2337/diabetes.53.10.2623 · Cited by 385
Aminotransferase Levels and 20-Year Risk of Metabolic Syndrome, Diabetes, and Cardiovascular Disease
Goessling, W., Massaro, J. M., Vasan, R. S., D'Agostino, R. B., Ellison, R. C., & Fox, C. S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.09.018 · Cited by 330
Canadian Health Measures Survey: rationale, background and overview.
Tremblay, M. S., Wolfson, M. C., & Gorber, S. C. (2007) · PubMed · Cited by 203
Lee, D. H., Silventoinen, K., Jacobs, D. R., Jousilahti, P., & Tuomileto, J. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0505 · Cited by 201
Prevalence of metabolic syndrome in the Canadian adult population
Riediger, N. D., & Clara, I. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.110070 · Cited by 192 · cited 2×
“In Canada, the prevalence of metabolic syndrome was found to be higher among people in households with lower education and income levels [3].”
BackgroundGamma‐glutamyl transpeptidase and the metabolic syndrome
Rantala, A. O., Lilja, M., Kauma, H., Savolainen, M. J., Reunanen, A., & Kesäniemi, Y. A. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00723.x · Cited by 140 · cited 1×
“Literature has suggested that high levels of GGT, even within the normal range, are an important predictor of increased risk of cardiovascular diseases and may reflect the development of MetS [15, 16, 22, 28, 34, 35].”
BackgroundMeisinger, C., Döring, A., Schneider, A. L. C., & Löwel, H. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.01.010 · Cited by 135
Tran, B. T., Jeong, B. Y., & Oh, J. (2017) · BMC Public Health · doi:10.1186/s12889-016-3936-6 · Cited by 124 · cited 1×
“), socioeconomic status (household income and education), lifestyle risk factors (personal cigarette smoking and alcohol consumption), environmental exposure (household smoking) are associated with MetS [18, 19].”
BackgroundKälsch, J., Bechmann, L. P., Heider, D., Best, J., Manka, P. P., Kälsch, H., Sowa, J., Moebus, S., Slomiany, U., Jöckel, K., et al. (2015) · Scientific Reports · doi:10.1038/srep13058 · Cited by 78
Association between Serum Liver Enzymes and Metabolic Syndrome in Korean Adults
Kim, H. R., & Han, M. A. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15081658 · Cited by 78 · cited 5×
“Baseline data from a current large populationbased study (N = 211,725) in 2019 in Korea showed that GGT level was significantly higher in subjects with MetS compared to normal subjects (37.92 ± 48.20 mg/ dL vs. 25.62 ± 33.56 mg/dL) [28].”
BackgroundResultInfluentialPatel, D. A., Srinivasan, S. R., Xu, J.-H., Chen, W., & Berenson, G. S. (2007) · Metabolism · doi:10.1016/j.metabol.2007.01.010 · Cited by 77
Schindhelm, R. K., Dekker, J. M., Nijpels, G., Stehouwer, C. D. A., Bouter, L. M., Heine, R. J., & Diamant, M. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02100.x · Cited by 75
Metabolic Syndrome and Serum Liver Enzymes in the General Chinese Population
Chen, S., Guo, X., Yu, S., Zhou, Y., Zhao, L., & Sun, Y. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13020223 · Cited by 73 · cited 3×
“In contrast, among Thai adults, elevated liver enzymes were significantly(?) related to MetS risk [11] and similar trends were found in Korean [13, 28] and Chinese [17] adults.”
BackgroundResultCanadian Health Measures Survey: clinic operations and logistics.
Bryan, S. N., St-Denis, M., & Wojtas, D. (2007) · PubMed · Cited by 71
Lee, D.-H., Jacobs, D. R., Gross, M., & Steffes, M. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.045872 · Cited by 70
Liu, C.-F., Zhou, W., & Fang, N.-Y. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2012.02959.x · Cited by 66 · cited 1×
“Literature has suggested that high levels of GGT, even within the normal range, are an important predictor of increased risk of cardiovascular diseases and may reflect the development of MetS [15, 16, 22, 28, 34, 35].”
BackgroundThe association between serum osteocalcin levels and metabolic syndrome in Koreans
Bae, S. J., Choe, J. W., Chung, Y. E., Kim, B., Lee, S. H., Kim, H. Y., Koh, J., Kim, H. Y., & Kim, G. S. (2010) · Osteoporosis International · doi:10.1007/s00198-010-1504-y · Cited by 54 · cited 1×
“Several observational studies [26, 40, 41] have suggested that serum ALKP activity may be higher in individuals with MetS versus in those without MetS, while others [42] did not find any statistically significant relationship.”
BackgroundAssociation between liver function and metabolic syndrome in Chinese men and women
Wang, S., Zhang, J., Zhu, L., Song, L., Meng, Z., Jia, Q., Li, X., Liu, N., Hu, T., Zhou, P., et al. (2017) · Scientific Reports · doi:10.1038/srep44844 · Cited by 53
Park, E. Y., Lim, M. K., Oh, J., Cho, H., Bae, M. J., Yun, E. H., Kim, D., & Shin, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063439 · Cited by 51
Kim, J., Lee, H. S., Park, H. M., & Lee, Y. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.10.015 · Cited by 51
Liver enzymes and metabolic syndrome: a large-scale case-control study
Zhang, L., Ma, X., Jiang, Z. D., Zhang, K., Zhang, M., Li, Y., Zhao, X., & Xiong, H. (2015) · Oncotarget · doi:10.18632/oncotarget.5792 · Cited by 44
γ-Glutamyltranspeptidase and Incident Stroke Among Japanese Men and Women
Shimizu, Y., Imano, H., Ohira, T., Kitamura, A., Kiyama, M., Okada, T., Sato, S., Shimamoto, T., Yamagishi, K., Tanigawa, T., et al. (2010) · Stroke · doi:10.1161/strokeaha.109.569061 · Cited by 43
Association between elevated liver enzymes and metabolic syndrome among Thai adults
Perera, S., Lohsoonthorn, V., Jiamjarasrangsi, W., Lertmaharit, S., & Williams, M. A. (2008) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2008.04.012 · Cited by 41 · cited 2×
“In contrast, among Thai adults, elevated liver enzymes were significantly(?) related to MetS risk [11] and similar trends were found in Korean [13, 28] and Chinese [17] adults.”
BackgroundResultEsteghamati, A., Jamali, A., Khalilzadeh, O., Noshad, S., Khalili, M. R., Zandieh, A., Morteza, A., & Nakhjavani, M. (2010) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-2-65 · Cited by 41
Serum alkaline phosphatase, body composition, and risk of metabolic syndrome in middle-aged Korean
Kim, M. K., Baek, K. H., Kang, M. I., Park, S. E., Rhee, E., Park, C., Lee, W., & Oh, K. W. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej12-0331 · Cited by 35 · cited 1×
“Several observational studies [26, 40, 41] have suggested that serum ALKP activity may be higher in individuals with MetS versus in those without MetS, while others [42] did not find any statistically significant relationship.”
BackgroundSteinvil, A., Shapira, I., Bassat, O. K., Cohen, M., Vered, Y., Berliner, S. A., & Rogowski, O. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-30 · Cited by 31
Koskinen, J. M., Magnussen, C. G., Kähönen, M. A. P., Loo, B.-M., Marniemi, J., Jula, A., Saarikoski, L. A., Huupponen, R., Viikari, J. S. A., Raitakari, O. T., et al. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.532152 · Cited by 27 · cited 1×
“[27] found no evidence that increased enzyme levels (ALT and GGT) would amplify the atherogenicity of MetS.”
BackgroundKohsari, M., Moradinazar, M., Rahimi, Z., Pasdar, Y., & Shakiba, E. (2021) · BioMed Research International · doi:10.1155/2021/5584452 · Cited by 25 · cited 1×
“19-fold increased risk for MetS compared with subjects in the first quartile [45].”
BackgroundCampbell, B., Aguilar, M. E. F., Bhuket, T. P., Torres, S., Liu, B., & Wong, R. J. (2016) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2016.06.014 · Cited by 23
Lee, M. Y., Hyon, D. S., Huh, J. H., Kim, H., Han, S. K., Kim, J., & Koh, S. B. (2019) · Endocrinology and Metabolism · doi:10.3803/enm.2019.34.4.390 · Cited by 22 · cited 2×
“Literature has suggested that high levels of GGT, even within the normal range, are an important predictor of increased risk of cardiovascular diseases and may reflect the development of MetS [15, 16, 22, 28, 34, 35].”
BackgroundResultGaeini, Z., Bahadoran, Z., Mirmiran, P., & Azizi, F. (2020) · Hepatitis Monthly · doi:10.5812/hepatmon.98535 · Cited by 22 · cited 1×
“38) in elevated ALKP levels compared with the subjects in the first tertile [44].”
BackgroundTao, L., Li, X., Zhu, H., Gao, Y., Luo, Y., Wang, W., Wang, Z., Chen, D., Wu, L., & Guo, X. (2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10115523 · Cited by 16 · cited 2×
“A high level of GGT was found to be positively associated with clustered components of MetS in another population-based study in Beijing, China in 2012 that considered10,553 adults aged 20–65 years [15].”
BackgroundHwang, A., Lin, Y., Liu, P.-T., Kao, Y.-M., & Chen, J. (2012) · Annals of Epidemiology · doi:10.1016/j.annepidem.2012.09.012 · Cited by 9
Han, K., Cho, D., Kim, Y., & Kim, K.-N. (2015) · Chinese Medical Journal · doi:10.4103/0366-6999.161343 · Cited by 6
Research works printed but not linked: 3
- Alberti K, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009;120(16):1640–1645. doi: 10.1161/CIRCULATIONAHA.109.192644. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
- Pitblado J. Survey data analysis in Stata. Stata Users Group, DC09 Stata Conference. 2009.
- Patel DA, Srinivasan SR, Xu JH, Chen W, Berenson GS. Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa heart study. Metabolism. 2007;56(6):792–798. doi: 10.1016/j.metabol.2007.01.010. [DOI] [PubMed] [Google Scholar] · DOI
Cited by
Vine, D., Ghosh, M., Wang, T., & Bakal, J. (2024) · CJC Open · doi:10.1016/j.cjco.2023.12.010 · Cited by 53
Dev, R., Behlouli, H., Parry, M., Raparelli, V., Norris, C. M., & Pilote, L. (2024) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.08.008 · Cited by 13
Maitland, S. B., Brauer, P. M., Mutch, D. M., Royall, D., Klein, D., Tremblay, A., Rhéaume, C., & Jeejeebhoy, K. N. (2024) · BMC Family Practice · doi:10.1186/s12875-024-02608-w · Cited by 2
“[9].”
Jamal, A., Babazono, A., Liu, N., Yamao, R., Fujita, T., Kim, S. A., & Li, Y. (2023) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2023.0055
Metadata
- Authors
- Chu, L. M., Karunanayake, C., Aich, P., Hecker, M., & Pahwa, P.
- Affiliations
- University of Saskatchewan (CA)
- National Institute of Science Education and Research (IN)
- Corresponding author
- Chu, Luan Manh
- Venue
- Journal of Diabetes & Metabolic Disorders
- Published
- 2022-09-17
- Volume
- 21
- Issue
- 2
- Pages
- 1699-1708
- ISSN
- 2251-6581 (ISSN-L)
- PMC
- PMC9672191
- OpenAlex
- W4296129469
- Cited by
- 4
- References
- 42
- Citations by year
- 2024: 1 · 2023: 3
- FWCI
- 0.72
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Journal of Diabetes & Metabolic Disorders (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- metabolic syndrome, liver enzymes, gamma-glutamyl transferase, aspartate aminotransferase, alkaline phosphatase, effect modification, body mass index, sex differences, age differences, Canadian adults, prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.